View by type:
Articles (4260)
Nigerian mums brave heat and stock-outs to get rotavirus vaccine
Rotavirus jabs used to cost Nigerians an often unaffordable US$13 a dose. Now available for free, they are an opportunity many mothers refuse to miss out on.
Zanzibar is on the path to eliminating cholera, researchers say
Outbreaks of cholera have blighted Zanzibar’s recent history, but in the last half decade, the deadly infection has been brought to heel.
What can we learn from HPV vaccine delivery costs?
New study results can inform planning and budgeting for sustainable human papillomavirus vaccination programs.
To Boost Gender Equity in the Sciences, Follow the Evidence
Some strategies used by universities and other institutions to hire and retain women are not rooted in research.
Vaccine exemptions in US children reach an all-time high
Immunisation rates for required vaccines remain below pre-pandemic levels.
Leading on vaccine equity: reflections on 100 days as interim CEO
The interim CEO of the Vaccine Alliance looks back on his first 100 days and looks forward to the challenges ahead.
Facemasks catch viruses – so why is the evidence on their effectiveness so confusing?
When it comes to assessing the efficacy of facemasks some types of trial are better than others, experts say.
Fading from global headlines, mpox continues to trouble its ‘cradle’ – DRC
“The fear of mpox looms over us daily,” health workers in Kinshasa say.
To Prevent the Next Pandemic, Follow the Science
The COVID-19 pandemic has underscored the critical role of evidence-based policies in addressing global health crises. It has also highlighted the need for flexible strategies, equitable health care, and multidisciplinary approaches that bridge…
Childhood pneumonia deaths “greatly reduced” in Kenya following PCV vaccination
Pneumonia is still the leading killer of young children world-wide, but Kenyan doctors and researchers say that rates of the lung infection have dipped substantially since pneumococcal conjugate vaccines were introduced in 2011.
How can we quantify the value of a vaccine?
Vaccine development for diseases that affect millions – such as tuberculosis and chikungunya – have languished; profiles that collate data on the value of such vaccines could change this.
Severe pneumonia in retreat since PCV jab, say Nepal health workers
After the pneumococcal conjugate vaccine was introduced in 2015, studies observed a major change in disease rates. Now health workers countrywide say the impact is evident.
